Related Experiment Video
Updated: Jul 5, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Cancerous miRNAs and their regulation
Xu-Bao Shi1, Clifford G Tepper, Ralph W deVere White
1Department of Urology, University of California, Davis, School of Medicine, Sacramento, California 95817, USA.
Abstract:
Although they account for only a very minor fraction of the expressed genome, microRNAs (miRNAs) are pivotal regulators of development and cellular homeostasis through their control of diverse cellular processes including proliferation, differentiation, apoptosis, survival, motility and morphogenesis. Accordingly, several miRNAs have been functionally classified as proto-oncogenes or tumor suppressors and are aberrantly expressed in different cancer types. Deregulation (e.g., overexpression or loss of expression) of these so-called "cancerous" miRNAs can figure prominently in tumor initiation and progression by elaborating an inappropriate cellular program promoting uncontrolled proliferation, favoring survival, inhibiting differentiation and/or promoting invasive behavior. These features would certainly promote tumor dissemination and persistence by favoring metastasis and therapy resistance. Cancerous miRNAs therefore represent attractive molecules for exploitation as biomarkers and therapeutic targets. In this review, we highlight recently characterized cancerous miRNAs and the mechanisms through which they contribute to the pathogenesis of human cancers. We also discuss the signal transduction pathways that regulate the expression of these miRNAs with particular attention to several essential transcription factors such as Myc, p53 and the androgen receptor.
Insights
MicroRNAs (miRNAs) are key gene regulators in development and cancer. Aberrant miRNA expression drives tumor growth, metastasis, and therapy resistance, making them promising cancer biomarkers and therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are crucial regulators of gene expression, impacting cellular processes like proliferation, differentiation, and apoptosis.
- Aberrant miRNA expression is linked to various human cancers, where they can act as proto-oncogenes or tumor suppressors.
Purpose of the Study:
- To review recently identified cancer-associated miRNAs and their roles in human cancer pathogenesis.
- To discuss the regulatory mechanisms of these miRNAs, including key transcription factors.
Main Methods:
- Literature review of recent studies on cancer-associated miRNAs.
- Analysis of miRNA roles in tumor initiation, progression, metastasis, and therapy resistance.
- Examination of signaling pathways and transcription factors (Myc, p53, androgen receptor) regulating miRNA expression.
Main Results:
- Cancer-associated miRNAs are implicated in uncontrolled proliferation, survival, inhibited differentiation, and invasive behavior.
- Deregulation of specific miRNAs contributes significantly to tumor initiation and progression.
- These miRNAs influence metastasis and therapy resistance, highlighting their clinical relevance.
Conclusions:
- Cancer-associated miRNAs are pivotal in human cancer development and progression.
- They represent valuable biomarkers for cancer diagnosis and prognosis.
- Targeting these miRNAs offers a promising therapeutic strategy for cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation

